TrialBMC cancer2013

Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer.

Marcelo Madeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.